The following tables summarize the amortized cost and estimated fair value of the Company’s marketable securities, which are considered to be available-for-sale investments (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2026 |
|
|
|
Amortized
Cost |
|
|
Unrealized
Gain |
|
|
Unrealized
Loss |
|
|
Fair
Value |
|
Marketable securities, current: |
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Treasury securities |
|
$ |
11,004 |
|
|
$ |
12 |
|
|
$ |
— |
|
|
$ |
11,016 |
|
Commercial paper |
|
|
5,469 |
|
|
|
— |
|
|
|
— |
|
|
|
5,469 |
|
Corporate debt securities |
|
|
14,332 |
|
|
|
— |
|
|
|
— |
|
|
|
14,332 |
|
Total marketable securities |
|
$ |
30,805 |
|
|
$ |
12 |
|
|
$ |
— |
|
|
$ |
30,817 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2025 |
|
|
|
Amortized
Cost |
|
|
Unrealized
Gain |
|
|
Unrealized
Loss |
|
|
Fair
Value |
|
Marketable securities, current: |
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Treasury securities |
|
$ |
30,049 |
|
|
$ |
75 |
|
|
$ |
— |
|
|
$ |
30,124 |
|
Commercial paper |
|
|
30,699 |
|
|
|
26 |
|
|
|
— |
|
|
|
30,725 |
|
Corporate debt securities |
|
|
25,162 |
|
|
|
33 |
|
|
|
— |
|
|
|
25,195 |
|
Total marketable securities |
|
$ |
85,910 |
|
|
$ |
134 |
|
|
$ |
— |
|
|
$ |
86,044 |
|
|